Cocrystal Pharma Inc. (COCP)

3Q23 Reported As Three Trials Make Progress


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
November 14, 2023
Report ID: 26267
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Cocrystal Pharma Inc.
Cocrystal Pharma Inc.
Healthcare
Biotechnology
Ticker
COCP
Current Price
$2.39 -8.43%
Market Cap
$24.3M
Price Target
Refer to Report
Volume
53.7K
52wk Range
$1.325 - $3.285
Related Research Reports
5/14/2024

1Q24 Reported With Clinical Data Milestones On Schedule
1Q24 Reported With Clinical Data Milestones On Schedule (COCP)
11/14/2023

3Q23 Reported As Three Trials Make Progress
3Q23 Reported As Three Trials Make Progress (COCP)
11/1/2023

Phase 2a Influenza Trial Receives Authorization To Begin
Phase 2a Influenza Trial Receives Authorization To Begin (COCP)
10/2/2023

CDI-988 Begins Phase 1a/b Clinical Trial
CDI-988 Begins Phase 1a/b Clinical Trial (COCP)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy